dawa-pharma-1.0 - SQL Injection via Email Parameter

published 2025-12-04 11 mo ago modified 2026-06-17 4 mo ago also EUVD-2025-201278

cvss: 8.7; version 4.0, CNA
cisa kev: Not listed; not in CISA's catalog
epss: 0.6%; EPSS 0.6% chance of exploitation in 30 days, percentile 47%
public exploits: 0; none known

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

CISA SSVC

Exploitation: Proof of concept is public
Automatable: yes
Technical impact: partial
Assessed: 11 mo ago (2025-12-05)

Exploit prediction

0.57% chance of exploitation in the next 30 days, higher than 47% of all scored CVEs (FIRST EPSS, 2026-11-08).

Exploits and checks

exploit-db.com https://www.exploit-db.com/exploits/51818 referenced PoC, tagged "exploit" by a source, unverified

CVSS scores

assigned by	version	score	vector
CNA	4.0	8.7	CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
CNA	4.0	8.7	CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Affected products

mayurik dawa-pharma

Classification

Weakness

CWE-89 Improper Neutralization of Special Elements used in an SQL Command

References

exploit-db.com /exploits/51818
exploit
mayurik.com /source-code/P0349/best-pharmacy-billing-software-free-download
product
github.com /nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/mayuri_k/2022/dawa-pharma-1.0-2022
product, issue-tracking
nu11secur1ty.com /
product
vulncheck.com /advisories/dawa-pharma-10-sql-injection-via-email-parameter
third-party-advisory

Sources

CVE List CVE-2023-53734
NVD CVE-2023-53734

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

Summary